Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with ...
Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) ...
MIT Technology Review5 分钟
Now read the rest of The Spark
That’s the question we tackle each year as we compile this annual list. The 2025 edition will be published in January. Here’s what won’t be on it. AI advances are rapidly speeding up the process of ...
Exeter toast much-needed victory over old foes Saracens
Bringing an intensity and bitter rivalry as strong as anything Storm Éowyn has delivered to these shores over the past 24 ...
wusf48 分钟
North Port: From cow pastures to booming. Here’s what that means
McDowell has been a North Port resident for 36 years. She said she saw North Port go from cow pastures and one lane roads to ...